Antonio Pisani
Antonio Pisani
Cattedra di Nefrologia UniversitÓ Federico II di Napoli
Email verificata su
Citata da
Citata da
Additive antiproteinuric effect of converting enzyme inhibitor and losartan in normotensive patients with IgA nephropathy
D Russo, A Pisani, MM Balletta, L De Nicola, FA Savino, M Andreucci, ...
American journal of kidney diseases 33 (5), 851-856, 1999
Coadministration of losartan and enalapril exerts additive antiproteinuric effect in IgA nephropathy
D Russo, R Minutolo, A Pisani, R Esposito, G Signoriello, M Andreucci, ...
American Journal of Kidney Diseases 38 (1), 18-25, 2001
Effect of longacting somatostatin analogue on kidney and cyst growth in autosomal dominant polycystic kidney disease (ALADIN): a randomised, placebo-controlled, multicentre trial
A Caroli, N Perico, A Perna, L Antiga, P Brambilla, A Pisani, B Visciano, ...
The Lancet 382 (9903), 1485-1495, 2013
Insomnia in maintenance haemodialysis patients
M Sabbatini, B Minale, A Crispo, A Pisani, A Ragosta, R Esposito, ...
Nephrology Dialysis Transplantation 17 (5), 852-856, 2002
Rituximab in steroid-dependent or frequently relapsing idiopathic nephrotic syndrome
P Ruggenenti, B Ruggiero, P Cravedi, M Vivarelli, L Massella, M MarasÓ, ...
Journal of the American Society of Nephrology 25 (4), 850-863, 2014
Acute kidney injury by radiographic contrast media: pathogenesis and prevention
M Andreucci, T Faga, A Pisani, M Sabbatini, A Michael
BioMed research international 2014, 2014
Metabolic effects of two low protein diets in chronic kidney disease stage 4–5—a randomized controlled trial
B Cianciaruso, A Pota, A Pisani, S Torraca, R Annecchini, P Lombardi, ...
Nephrology Dialysis Transplantation 23 (2), 636-644, 2008
Enzyme replacement therapy with agalsidase β improves cardiac involvement in Fabry's disease
L Spinelli, A Pisani, M Sabbatini, M Petretta, MV Andreucci, D Procaccini, ...
Clinical genetics 66 (2), 158-165, 2004
Effect of oral liposomal iron versus intravenous iron for treatment of iron deficiency anaemia in CKD patients: a randomized trial
A Pisani, E Riccio, M Sabbatini, M Andreucci, A Del Rio, B Visciano
Nephrology dialysis transplantation 30 (4), 645-652, 2015
Prevention of contrast-induced nephropathy through a knowledge of its pathogenesis and risk factors
M Andreucci, T Faga, A Pisani, M Sabbatini, D Russo, A Michael
The Scientific World Journal 2014, 2014
Sleep quality in renal transplant patients: a never investigated problem
M Sabbatini, A Crispo, A Pisani, R Gallo, B Cianciaruso, G Fuiano, ...
Nephrology Dialysis Transplantation 20 (1), 194-198, 2005
Enzyme replacement therapy in patients with Fabry disease: state of the art and review of the literature
A Pisani, B Visciano, GD Roux, M Sabbatini, C Porto, G Parenti, ...
Molecular genetics and metabolism 107 (3), 267-275, 2012
Role of reactive oxygen species in pathogenesis of radiocontrast-induced nephropathy
A Pisani, E Riccio, M Andreucci, T Faga, M Ashour, A Di Nuzzi, A Mancini, ...
BioMed research international 2013, 2013
Effect of a low-versus moderate-protein diet on progression of CKD: follow-up of a randomized controlled trial
B Cianciaruso, A Pota, V Bellizzi, D Di Giuseppe, L Di Micco, R Minutolo, ...
American Journal of Kidney Diseases 54 (6), 1052-1061, 2009
The ischemic/nephrotoxic acute kidney injury and the use of renal biomarkers in clinical practice
M Andreucci, T Faga, A Pisani, M Perticone, A Michael
European Journal of Internal Medicine 39, 1-8, 2017
Effects of enzyme-replacement therapy in patients with Anderson–Fabry disease: a prospective long-term cardiac magnetic resonance imaging study
M Imbriaco, A Pisani, L Spinelli, A Cuocolo, G Messalli, E Capuano, ...
Heart 95 (13), 1103-1107, 2009
Atorvastatin improves the course of ischemic acute renal failure in aging rats
M Sabbatini, A Pisani, F Uccello, V Serio, R Ser¨, R Patern˛, ...
Journal of the American Society of Nephrology 15 (4), 901-909, 2004
Oral tacrolimus long‐term therapy in patients with Crohn’s disease and steroid resistance
E Ierardi, M Principi, R Francavilla, A Pisani, M Rendina, M Ingrosso, ...
Alimentary pharmacology & therapeutics 15 (3), 371-377, 2001
Enzyme replacement therapy in Fabry disease patients undergoing dialysis: effects on quality of life and organ involvement
A Pisani, L Spinelli, M Sabbatini, MV Andreucci, D Procaccini, ...
American journal of kidney diseases 46 (1), 120-127, 2005
Rapamycin for treatment of type I autosomal dominant polycystic kidney disease (RAPYD-study): a randomized, controlled study
G Stallone, B Infante, G Grandaliano, C Bristogiannis, L Macarini, ...
Nephrology Dialysis Transplantation 27 (9), 3560-3567, 2012
Il sistema al momento non pu˛ eseguire l'operazione. Riprova pi¨ tardi.
Articoli 1–20